Abstract
Recent evidence has revealed that exposing cells to exogenous H 2 S or inhibiting cellular H 2 S synthesis can modulate cell cycle checkpoints, DNA damage and repair, and the expression of proteins involved in the maintenance of genomic stability, all suggesting that H 2 S plays an important role in the DNA damage response (DDR). Here we review the role of H 2 S in the DRR and maintenance of genomic stability. Treatment of various cell types with pharmacologic H 2 S donors or cellular H 2 S synthesis inhibitors modulate the G 1 checkpoint, inhibition of DNA synthesis, and cause p21, and p53 induction. Moreover, in some cell models H 2 S exposure induces PARP-1 and g-H2AX foci formation, increases PCNA, CHK2, Ku70, Ku80, and DNA polymerase-d protein expression, and maintains mitochondrial genomic stability. Our group has also revealed that H 2 S bioavailability and the ATR kinase regulate each other with ATR inhibition lowering cellular H 2 S concentrations, whereas intracellular H 2 S concentrations regulate ATR kinase activity via ATR serine 435 phosphorylation. In summary, these findings have many implications for the DDR, for cancer chemotherapy, and fundamental biochemical metabolic pathways involving H 2 S.
References
Mar 15, 2001·Current Opinion in Cell Biology·D Durocher, S P Jackson
Nov 5, 2002·Journal of Cell Science·Holly CapassoNancy C Walworth
Mar 18, 2003·Nature Genetics·Mark O'DriscollJudith A Goodship
Apr 3, 2003·Experimental Biology and Medicine·Bart DeplanckeH Rex Gaskins
Sep 25, 2004·Journal of Cellular Physiology·Hongyan WangGeorge Iliakis
Oct 18, 2006·Oncogene·P J HurleyF Bunz
Nov 23, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rajamanickam BaskarPhilip Keith Moore
Nov 28, 2006·Toxicology Letters·Mario GreenRonald D Thomas
May 4, 2007·Molecular Cancer Research : MCR·Matias S Attene-RamosMichael J Plewa
Dec 19, 2007·Journal of Periodontal Research·H TakeuchiY Izumi
Oct 23, 2008·Journal of Periodontal Research·K YaegakiT Kamoda
Feb 9, 2011·European Journal of Pharmacology·Rajamanickam Baskar, Jinsong Bian
Dec 22, 2011·The Tohoku Journal of Experimental Medicine·Xinxing XieJunbo Ge
May 9, 2012·Free Radical Biology & Medicine·Xinggui ShenChristopher G Kevil
Oct 4, 2012·Journal of Periodontal Research·B CalenicT Tanaka
Mar 16, 2013·British Journal of Pharmacology·Antonia AsimakopoulouAndreas Papapetropoulos
May 25, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·F TalaeiR H Henning
Apr 30, 2014·EMBO Reports·Kexin ZhaoGuangdong Yang
Jun 21, 2014·Molecular Cell·Stuart G JarrettJohn A D'Orazio
Mar 12, 2015·Antioxidants & Redox Signaling·Shuangshuang Li, Guangdong Yang
Oct 29, 2015·DNA Repair·Philip C Hanawalt
Dec 29, 2015·Frontiers in Bioscience (Landmark Edition)·Siamak Tabibzadeh
Nov 4, 2016·Scientific Reports·Bartosz SzczesnyCsaba Szabo
Aug 16, 2017·Nature Reviews. Molecular Cell Biology·Joshua C SaldivarKarlene A Cimprich
Oct 6, 2017·Pharmacological Reviews·Csaba Szabo, Andreas Papapetropoulos
Oct 22, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Zhaojun QiuJunran Zhang
May 14, 2018·FEBS Letters·Jon M FukutoTakaaki Akaike
May 24, 2018·Antioxidants & Redox Signaling·Xu CaoJin-Song Bian
Jul 5, 2018·Anticancer Research·Andrew T MeramRodney E Shackelford
Oct 5, 2018·Case Reports in Oncology·Kim DongsooRodney E Shackelford
Nov 7, 2018·Anticancer Research·Elba A Turbat-HerreraRodney E Shackelford
Nov 25, 2018·DNA Repair·Jie ChenRodney E Shackelford
Nov 30, 2018·Case Reports in Oncology·Dongsoo KimRodney E Shackelford
Jun 9, 2019·Redox Biology·Adam Y XiaoLynn Harrison
Oct 18, 2019·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Magdalena C Liebl, Thomas G Hofmann
May 6, 2020·Biomolecules·Karim ZuhraCsaba Szabo